Electrochemical monitoring of transport by a vesicular monoamine transporter expressed in Xenopus oocytes

Journal of Neuroscience Methods

Volumn 133, Issue 1-2, 2004, Pages 191-199

  Whitley, Janet ^a,c   Parsons, Jessica ^a   Freeman, Jeffrey ^a   Liu, Yongjian ^b,d   Edwards, Robert H ^b   Near, Joseph A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Electrochemistry; Synaptic vesicle; Transport; Uptake; Vesicular monoamine transporter; Voltammetry

Indexed keywords

BUFFER; CARBON FIBER; DIHYDROTETRABENAZINE; DOPAMINE; MESSENGER RNA; MONOAMINE; PROTEIN; TRITIUM; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER; WATER;

ANIMAL CELL; ARTICLE; CALIBRATION; CELL MEMBRANE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; ELECTROCHEMISTRY; ENDOCYTOSIS; FEASIBILITY STUDY; MICROELECTRODE; MODEL; NONHUMAN; OOCYTE; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS LAEVIS;

EID: 0742306844     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2003.10.010     Document Type: Article

References (38)

1. Bannon M.J., Xue C.H., Shibata K., Dragovic L.J., Kapatos G. Expression of a human cocaine-sensitive dopamine transporter in Xenopus laevis oocytes. J. Neurochem. 54:1990;706-708.
2. Beers M.F., Carty S.E., Johnson R.G., Scarpa A. H+-ATPase and catecholamine transport in chromaffin granules. Ann. N. Y. Acad. Sci. 402:1982;116-133.
3. Carty S.E., Johnson R.G., Vaughan T., Pallant A., Scarpa A. Amine transport into chromaffin ghosts. Kinetic measurements of net uptake of biologically and pharmacologically relevant amines using an on-line amperometric technique. Eur. J. Biochem. 147:1985;447-452.
4. Edwards R.H. The transport of neurotransmitters into synaptic vesicles. Curr. Opin. Neurobiol. 2:1992;586-594.
5. Erickson J.D., Eiden L.E., Hoffman B.J. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10993-10997.
6. Finn J.P., Edwards R.H. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2. J. Biol. Chem. 273:1998;3943-3947.
7. Gasnier B., Krejci E., Botton D., Massoulie J., Henry J.P. Expression of a bovine vesicular monoamine transporter in COS cells. FEBS Lett. 342:1994;225-229.
8. Gurdon J.B. The translation of messenger RNA injected in living oocytes of Xenopus laevis. Acta Endocrinol. Suppl. 180:1973;225-243.
9. Hediger M.A., Ikeda T., Coady M., Gundersen C.B., Wright E.M. Expression of size-selected mRNA encoding the intestinal Na/glucose cotransporter in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. U.S.A. 84:1987;2634-2637.
10. Henry J.P., Gasnier B., Roisin M.P., Isambert M.F., Scherman D. Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane. Ann. N. Y. Acad. Sci. 493:1987;194-206.
11. Henry J.P., Sagne C., Bedet C., Gasnier B. The vesicular monoamine transporter: from chromaffin granule to brain. Neurochem. Int. 32:1998;227-246.
12. Johnson R.G. Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol. Rev. 68:1988;232-307.
13. Kanner B.I., Schuldiner S. Mechanism of transport and storage of neurotransmitters. Crit. Rev. Biochem. 22:1987;1-38.
14. Kawagoe K.T., Zimmerman J., Wightman R.M. Principles of voltammetry and microelectrode surface states. J. Neurosci. Methods. 48:1993;225-240.
15. Kilbourn M., Lee L., Vanderborght T., Jewett D., Frey K. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. Eur. J. Pharmacol. 278:1995;249-252.
16. Kitayama S., Morita K., Dohi T. Uptake and release of dopamine through the rat dopamine transporter expressed in Xenopus laevis oocyte: evaluation by voltammetric measurement of intracellular dopamine concentration. Neurosci. Lett. 211:1996;132-134.
17. Liu Y.J., Edwards R.H. The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu. Rev. Neurosci. 20:1997;125-156.
18. Liu Y., Peter D., Roghani A., Schuldiner S., Prive G.G., Eisenberg D., Brecha N., Edwards R.H. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell. 70:1992;539-551.
19. Liu Y., Schweitzer E.S., Nirenberg M.J., Pickel V.M., Evans C.J., Edwards R.H. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J. Cell Biol. 127:1994;1419-1433.
20. Liu Y.J., Peter D., Merickel A., Krantz D., Finn J.P., Edwards R.H. A molecular analysis of vesicular amine transport. Behav. Brain Res. 73:1995;51-58.
21. Liu Y., Waites C., Krantz D., Tan P., Edwards R.H. Molecular analysis of neurotransmitter transport into secretory vesicles. Cold Spring Harb. Symp. Quant. Biol. 61:1996;747-758.
22. Merickel A., Edwards R.H. Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology. 34:1995;1543-1547.
23. Michael D.J., Wightman R.M. Electrochemical monitoring of biogenic amine neurotransmission in real time. J. Pharm. Biomed. Anal. 19:1999;33-46.
24. 3H ]Dihydrotetrabenazine binding to bovine striatal synaptic vesicles Mol. Pharmacol. 30:1986;252-257.
25. Parsons S.M. Transport mechanisms in acetylcholine and monoamine storage. FASEB J. 14:2000;2423-2434.
26. Peter D., Jimenez J., Liu Y.J., Kim J., Edwards R.H. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269:1994;7231-7237.
27. Pletcher A., Brossi A., Gey K.F. Benzoquinolizine derivatives: a new class of monoamine decreasing drugs with psychotropic action. Int. Rev. Neuro. Biol. 4:1962;275-306.
28. Sarthy V. Gamma-Aminobutyric acid (GABA) uptake by Xenopus oocytes injected with rat brain mRNA. Brain Res. 387:1986;97-100.
29. Scherman D., Henry J.-P. Effect of drugs on the ATP-induced and pH-gradient-driven monoamine transport by bovine chromaffin granules. Biochem. Pharmacol. 29:1980;1883-1890.
30. Scherman D., Henry J.P. The catecholamine carrier of bovine chromaffin granules. Form of the bound amine. Mol. Pharmacol. 23:1983;431-436.
31. Scherman D., Jaudon P., Henry J.-P. Characterization of the monoamine carrier of chromaffin granule membrane by binding of 2-[3H]dihydrotetrabenazine. Proc. Natl. Acad. Sci. U.S.A. 80:1983;584-588.
32. Scheuner D., Logsdon C.D., Holz R.W. Bovine chromaffin granule membranes undergo Ca(2+)-regulated exocytosis in frog oocytes. J. Cell Biol. 116:1992;359-365.
33. Sigel E. Use of Xenopus oocytes for the functional expression of plasma membrane proteins. J. Membr. Biol. 117:1990;201-221.
34. Smart TG, Krishek BJ. Xenopus oocyte microinjection and ion-channel expression. In: Boulton AA, Baker GB, Walz W, editors. Patch-clamp applications and protocols. Totowa (NJ): Humana Press; 1995. p. 259-305.
35. Stern-Bach Y., Greenberg-Ofrath N., Flechner I., Schuldiner S. Identification and purification of a functional amine transporter from bovine chromaffin granules. J. Biol. Chem. 265:1990;3961-3966.
36. Tan P.K., Waites C., Liu Y.J., Krantz D.E., Edwards R.H. A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters. J. Biol. Chem. 273:1998;17351-17360.
37. Wightman R.M., Jankowski J.A., Kennedy R.T., Kawagoe K.T., Schroeder T.J., Leszczyszyn D.J., Near J.A., Diliberto E.J., Viveros O.H. Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10754-10758.
38. Zucker M., Weizman A., Rehavi M. Characterization of high-affinity [H-3]TBZOH binding to the human platelet vesicular monoamine transporter. Life Sci. 69:2001;2311-2317.